skip to content

Investment Research For Regular People

Conflict-Free Research on Investments: Stocks, Funds, IPOs

  • 5i Research works only for you.
  • We are conflict-free.
  • Our research is independent.

No one else in the investment industry can honestly say that.

Become a Member

Peter Hodson and Ryan Modesto

5i Recent Blog Posts


Stock Screener - Revenue Growth

For this months stock market screen, we take a look at companies showing above average revenue growth.

Moez M Sep 16, 2018
5i Recent Questions

Q: Re my question on H-IR, the receipts are trading around $27 and H is trading around $19 - 20. If the deal goes through what do I get for one H-IR? The press release which I read, and which you quoted did not make this clear to me. I assume I would not be trading a $27 H-IR for a share of H worth $20. (or would I ?)
And, also, what specifically would I receive if the deal does not go through?
Thanks,

Read Answer Asked by Peter on September 25, 2018
5i Recent Reports
Rating
B+

Review of Knight Therapeutics

SEP 19, 2018 - Specialty Pharmaceutical company focused on later stage commercialization of drugs. The company continues to hold on to a high balance of cash, waiting for the right opportunity. Despite strong fundamentals and management, the increased opportunity cost and stock trading sideways justify the rating to be downgraded one notch to 'B+'.

Download Report
Rating
C

Review of DHX Media

SEP 19, 2018 - Global children's entertainment firm facing huge headwinds. Lowered guidance, competition, high debt, and ongoing strategic review are some key negatives. Rating downgraded to 'C'.

Download Report
Rating
B+

Review of TFI International

AUG 30, 2018 - Transportation and logistics company growing through acquisition and facing a positive economic backdrop all while holding a cheap valuation. Initiating coverage at a 'B+' rating.

Download Report
Rating
B

Review of Stantec Inc

AUG 30, 2018 - Professional engineering firm with big market share facing headwinds and stagnant growth. Rating downgraded two notches to 'B'.

Download Report
Rating
B-

Review of Canaccord Genuity

AUG 27, 2018 - Independent financial services company trying to be less volatile with an increased focus towards wealth management and capitalizing on increasing number of deals in the cannabis sector. Rating upgraded a notch to 'B-'.

Download Report